citric acid, anhydrous has been researched along with Mitochondrial Diseases in 3 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, Y | 1 |
| Haraguchi, A | 1 |
| Shigeno, R | 1 |
| Ito, A | 1 |
| Horie, I | 1 |
| Kawakami, A | 1 |
| Abiru, N | 1 |
| Shimura, M | 1 |
| Nozawa, N | 1 |
| Ogawa-Tominaga, M | 1 |
| Fushimi, T | 1 |
| Tajika, M | 1 |
| Ichimoto, K | 1 |
| Matsunaga, A | 1 |
| Tsuruoka, T | 1 |
| Kishita, Y | 1 |
| Ishii, T | 1 |
| Takahashi, K | 1 |
| Tanaka, T | 1 |
| Nakajima, M | 1 |
| Okazaki, Y | 1 |
| Ohtake, A | 1 |
| Murayama, K | 1 |
| Roe, CR | 1 |
| Brunengraber, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 2A/2B Placebo-controlled Randomised Clinical Trial to Test the Ability of Triheptanoin to Protect Primary Airway Epithelial Cells Obtained From Participants With Ataxia-telangiectasia Against Death Induced by Glucose Deprivation[NCT04513002] | Phase 2 | 30 participants (Actual) | Interventional | 2022-03-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for citric acid, anhydrous and Mitochondrial Diseases
| Article | Year |
|---|---|
A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus.
Topics: Adenosine Triphosphate; Adult; Aminolevulinic Acid; Blood Glucose; Citric Acid; Deafness; Diabetes M | 2021 |
2 other studies available for citric acid, anhydrous and Mitochondrial Diseases
| Article | Year |
|---|---|
Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Biosynthetic Pathways; Case-Control Studies; Citric Aci | 2019 |
Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience.
Topics: Administration, Oral; Adolescent; Adult; Carnitine; Child; Child, Preschool; Citric Acid; Fatty Acid | 2015 |